(Q40119372)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18306371%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

title

Age and gender are significant independent predictors of survival in primary cutaneous melanoma (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18306371%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18306371%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

Thomas Kurt Eigentler

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18306371%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

Claus Garbe

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18306371%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

author name string

Konstantinos Lasithiotakis

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18306371%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

Friedegund Meier

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18306371%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

Gizela Metzler

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18306371%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

Matthias Moehrle

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18306371%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

Helmut Breuninger

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18306371%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

language of work or name

English

0 references

publication date

1 April 2008

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18306371%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

number of pages

10

1 reference

inferred from page(s)

published in

Cancer

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18306371%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

volume

112

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18306371%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

issue

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18306371%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

page(s)

1795-1804

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18306371%20AND%20SRC:MED&resulttype=core&format=json

Melanoma incidence and mortality in Scotland 1979-2003.

3 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23359

7 January 2021

The incidence and mortality of cutaneous melanoma in Southern Germany: trends by anatomic site and pathologic characteristics, 1976 to 2003.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23359

7 January 2021

Recent Trends in Cutaneous Melanoma Incidence Among Whites in the United States

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23359

7 January 2021

Trends in the incidence of cutaneous malignant melanoma in New South Wales, 1983-1996.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23359

7 January 2021

Recent cohort trends in malignant melanoma by anatomic site in the United States.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23359

7 January 2021

Improvement of overall survival of patients with cutaneous melanoma in Germany, 1976-2001: which factors contributed?

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23359

7 January 2021

Prognostic factors analysis of 17,600 melanoma patients: validation of the American Joint Committee on Cancer melanoma staging system

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23359

7 January 2021

Time trends of cutaneous melanoma in Queensland, Australia and Central Europe

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23359

7 January 2021

A Community Study of Delay in Presenting With Signs of Melanoma to Medical Practitioners

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23359

7 January 2021

Signs and symptoms of melanoma in older populations

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23359

7 January 2021

Nodular melanoma: patients' perceptions of presenting features and implications for earlier detection

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23359

7 January 2021

Early diagnosis of cutaneous melanoma: revisiting the ABCD criteria

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23359

7 January 2021

Diagnosis of melanoma in the elderly and surgical implications.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23359

7 January 2021

Factors involved in presentation of older people with thick melanoma.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23359

7 January 2021

Age as a prognostic factor in the malignant melanoma population

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23359

7 January 2021

Correlation between prognostic factors and increasing age in melanoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23359

7 January 2021

Serious co-morbidity among unselected cancer patients newly diagnosed in the southeastern part of The Netherlands in 1993-1996.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23359

7 January 2021

A wide difference in cancer survival between middle aged and elderly patients in Europe.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23359

7 January 2021

Determinants of cancer therapy in elderly patients.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23359

7 January 2021

Underrepresentation of patients 65 years of age or older in cancer-treatment trials

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23359

7 January 2021

Participation of patients 65 years of age or older in cancer clinical trials

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23359

7 January 2021

Superior survival of young women with malignant melanoma.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23359

7 January 2021

Increased thickness of pregnancy-associated melanoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23359

7 January 2021

A phase III randomized trial of dacarbazine and carboplatin with and without tamoxifen in the treatment of patients with metastatic melanoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23359

7 January 2021

The prognostic importance of tumor mitotic rate confirmed in 1317 patients with primary cutaneous melanoma and long follow-up

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23359

7 January 2021

Sentinel-node biopsy or nodal observation in melanoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23359

7 January 2021